Mickael Decressac, Ph.D

Affiliations: 
Wallenberg Neuroscience Center Lund University, Lund, Skåne län, Sweden 
Area:
Parkinson's disease
Google:
"Mickael Decressac"
Mean distance: 15.36 (cluster 11)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tozzi A, de Iure A, Bagetta V, et al. (2016) Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit. Biological Psychiatry. 79: 402-14
Tamburrino A, Churchill MJ, Wan OW, et al. (2015) Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson's disease. Acta Neuropathologica Communications. 3: 84
Volakakis N, Tiklova K, Decressac M, et al. (2015) Nurr1 and Retinoid X Receptor Ligands Stimulate Ret Signaling in Dopamine Neurons and Can Alleviate α-Synuclein Disrupted Gene Expression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 14370-85
Decressac M, Volakakis N, Björklund A, et al. (2013) NURR1 in Parkinson disease--from pathogenesis to therapeutic potential. Nature Reviews. Neurology. 9: 629-36
Decressac M, Björklund A. (2013) mTOR inhibition alleviates L-DOPA-induced dyskinesia in parkinsonian rats. Journal of Parkinson's Disease. 3: 13-7
Decressac M, Björklund A. (2013) TFEB: Pathogenic role and therapeutic target in Parkinson disease. Autophagy. 9: 1244-6
Decressac M, Mattsson B, Weikop P, et al. (2013) TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity. Proceedings of the National Academy of Sciences of the United States of America. 110: E1817-26
Kadkhodaei B, Alvarsson A, Schintu N, et al. (2013) Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons. Proceedings of the National Academy of Sciences of the United States of America. 110: 2360-5
Decressac M, Kadkhodaei B, Mattsson B, et al. (2012) α-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons. Science Translational Medicine. 4: 163ra156
Decressac M, Barker RA. (2012) Neuropeptide Y and its role in CNS disease and repair. Experimental Neurology. 238: 265-72
See more...